Dogne Jean-Michel
Université de Namur
H-index: 60
Europe-Belgium
Top articles of Dogne Jean-Michel
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model | European Journal of Obstetrics and Gynecology and Reproductive Biology | Morimont Laure MD Creinin JM Dogné JM Foidart J Douxfils | 2024/2/1 |
Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273. | Virology | Constant Gillot Marie Tré-Hadry Roberto Cupaiolo Laurent Blairon Alain Wilmet | 2024/4/8 |
Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: the devil is in the details. | medRxiv | Charlotte Beaudart Jonathan Douxfils Flora Musuamba Jean-Michel Dogne | 2024 |
Neutralizing antibody response to XBB. 1.5, BA. 2.86, FL. 1.5. 1 and JN. 1 six months after the BNT162b2 bivalent booster | International Journal of Infectious Diseases | Julien Favresse Constant Gillot Julien Cabo Clara David Jean-Michel Dogné | 2024/4/5 |
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster | Journal of medical virology | Julien Favresse Constant Gillot Mélanie Closset Julien Cabo Loris Wauthier | 2024/1 |
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure? | Thrombosis research | Julie Vassart Marie Didembourg Laure Morimont Clotilde Brisbois Laurent Jamart | 2024/4/1 |
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort | Microbiology Research | Constant Gillot Julien Favresse Clara David Vincent Maloteau Jean-Michel Dogne | 2024/3/21 |
How safe is fezolinetant for the treatment of vasomotor symptoms? | Jonathan Douxfils Charlotte Beaudart Jean-Michel Dogné | 2024/4/27 | |
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks | Nature aging | Lize Cuypers Els Keyaerts Samuel Leandro Hong Sarah Gorissen Soraya Maria Menezes | 2023/6 |
Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster | Journal of medical virology | Julien Favresse Constant Gillot Jean‐Louis Bayart Clara David Germain Simon | 2023/1 |
Evaluation of neutralizing capacity of tixagevimab plus cilgavimab: a case-series study with comparison to a vaccinated population | Constant Gillot Jean-Louis Bayart Vincent Maloteau Jean-Michel Dogné Jonathan Douxfils | 2023/10/13 | |
Low thrombin generation in users of a contraceptive containing estetrol and drospirenone | The Journal of Clinical Endocrinology & Metabolism | Laure Morimont Maud Jost Ulysse Gaspard Jean-Michel Foidart Jean-Michel Dogné | 2023/1/1 |
Safety Monitoring of COVID‐19 Vaccines: Perspective from the European Medicines Agency | Julie Durand Jean‐Michel Dogné Catherine Cohet Kate Browne María Gordillo‐Marañón | 2023/6 | |
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 … | Clinical Chemistry and Laboratory Medicine (CCLM) | Germain Simon Julien Favresse Constant Gillot Mélanie Closset Émilie Catry | 2023/9/26 |
Humoral and cellular response three months following bivalent booster administration | Julien Favresse Constant Gillot Jean-Louis Bayart Mélanine Closset Loris Wauthier | 2023/5/11 | |
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing | Clinical Chemistry and Laboratory Medicine (CCLM) | Constant Gillot Jean-Louis Bayart Mélanie Closset Julien Cabo Vincent Maloteau | 2023/8/28 |
Evaluation of Sivelestat as a NETosis inhibitor using an in-house ex-vivo model | Constant Gillot Pauline Michaux Julien FAVRESSE Marielle Herzog Terry Kelly | 2023/11/30 | |
Challenges in assessing COVID-19 vaccines safety signals—the case of ChAdOx1 nCoV-19 vaccine and corneal graft rejection | Vaccines | Christelle Bizimungu Martine Sabbe Françoise Wuillaume Jamila Hamdani Philippe Koch | 2023/5/6 |
Moving Toward a Question‐Centric Approach for Regulatory Decision Making in the Context of Drug Assessment | Flora T Musuamba SY Amy Cheung Pieter Colin Elin H Davies Jeffrey S Barret | 2023/7 | |
Risk of neoplasm with the neurokinin 3 receptor antagonist fezolinetant | The Lancet | Jonathan Douxfils Charlotte Beaudart Jean-Michel Dogné | 2023/11/4 |
Co-Authors
